C. Allimant
YOU?
Author Swipe
View article: P167 The variation of faecal calprotectin level within the first months after bowel resection is predictive of endoscopic postoperative recurrence in patients with Crohn’s disease
P167 The variation of faecal calprotectin level within the first months after bowel resection is predictive of endoscopic postoperative recurrence in patients with Crohn’s disease Open
International audience
View article: P163 Transmural healing assessed using MRI scores is associated with better outcomes and is a potential therapeutic target in patients with Crohn’s disease
P163 Transmural healing assessed using MRI scores is associated with better outcomes and is a potential therapeutic target in patients with Crohn’s disease Open
The poor acceptability of repeated colonoscopies limits the use of endoscopic mucosal healing as therapeutic target in patients with Crohn’s disease (CD). MRI is better accepted than endoscopy, is able to perform a concomitant assessment o…
View article: DOP80 Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial
DOP80 Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial Open
Postoperative recurrence is a major concern in patients with Crohn’s disease (CD). Curcumin exhibited anti-inflammatory and anti-oxidative properties in cellular and rodent models. Recently, a randomised controlled trial demonstrated that …
View article: Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence Open
Faecal calprotectin and MRI are two reliable tools to detect endoscopic POR in patients with CD.
View article: P304 Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn’s disease
P304 Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn’s disease Open
Mucosal healing (MH) is to date the most validated target in Crohn’s disease (CD). However, its use is limited by the low acceptability of repeated endoscopies. In this context, faecal calprotectin (Fcal) is a more convenient tool to monit…
View article: DOP013 Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study)
DOP013 Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study) Open
Background: As Crohn's disease (CD) presents with transmural inflammation, mucosal healing remains an imperfect target. Magnetic resonance enterocolonography (MREC) has been showed as a reliable tool to assess CD activity. However, the def…
View article: P123 MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease
P123 MRI remission after therapeutic intervention is associated with more time spent in clinical corticosteroids-free remission and decreased risk of surgery in Crohn's disease Open
Background: Endoscopic mucosal healing should be the therapeutic goal in Crohn's disease (CD) as it is associated with more favourable outcomes. Alternative non-invasive approach, such as magnetic resonance imaging (MRI), is able to detect…
View article: P122 Magnetic resonance index of activity (MaRIA) and Clermont score are two MRI indices which are highly and equally effective in detecting mucosal healing in Crohn's disease
P122 Magnetic resonance index of activity (MaRIA) and Clermont score are two MRI indices which are highly and equally effective in detecting mucosal healing in Crohn's disease Open
Background: Mucosal healing is hitherto the most popular therapeutic endpoint in Crohn's disease (CD) and is currently defined as no endoscopic ulcers. Magnetic resonance imaging (MRI)is an accurate examination for assessing activity in CD…
View article: P572 Medical therapies for stricturing Crohn's disease: efficacy and cross-sectional imaging predictors of therapeutic failure
P572 Medical therapies for stricturing Crohn's disease: efficacy and cross-sectional imaging predictors of therapeutic failure Open
Background: Medical therapy efficacy remains controversial in stricturing Crohn's disease. In the present study, we aimed to assess the long-term impact of medical therapies in stricturing CD and to identify both the clinical and radiologi…
View article: P628 Anti-TNF therapy in refractory pouchitis and Crohn's disease-like complications of the pouch after ileal pouch-anal anastomosis following colectomy for ulcerative colitis: a systematic review and meta-analysis
P628 Anti-TNF therapy in refractory pouchitis and Crohn's disease-like complications of the pouch after ileal pouch-anal anastomosis following colectomy for ulcerative colitis: a systematic review and meta-analysis Open
Background: Pouchitis and secondary Crohn's disease (CD)-like complication of the pouch are the most common complications after ileal pouch-anal anastomosis following colectomy for ulcerative colitis. Data about the effectiveness of anti-T…
View article: P272 Faecal calprotectin and magnetic resonance imaging are highly accurate to detect endoscopic postoperative recurrence in Crohn's disease
P272 Faecal calprotectin and magnetic resonance imaging are highly accurate to detect endoscopic postoperative recurrence in Crohn's disease Open
Background: The POCER trial [1] has recently confirmed that the therapeutic management has to be adapted according to endoscopic findings within the first year following surgery to prevent postoperative recurrence (POR) in Crohn's disease …